Clinical Evidence: What STEP and SURMOUNT Trials Reveal
Understanding Wegovy vs Mounjaro Doses: Mechanism Differences
When comparing Wegovy vs Mounjaro doses, the fundamental difference lies in their mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, reducing appetite and promoting satiety after smaller meals. Mounjaro contains tirzepatide, a dual agonist targeting both GIP and GLP-1 receptors, potentially affecting glucose metabolism and appetite through two pathways.
This mechanistic difference influences their dosing schedules and how patients experience their effects. Wegovy follows a structured five-step dose escalation over 16 weeks (0.25mg, 0.5mg, 1mg, 1.7mg, then 2.4mg maintenance), while Mounjaro uses four escalation steps reaching 15mg maximum dose. Both prescription-only medicines require careful titration to minimise gastrointestinal side effects whilst optimising therapeutic benefits.
Wegovy vs Mounjaro Doses: UK Pricing and Value Analysis
EverydayMeds pricing for Wegovy vs Mounjaro doses reflects their different supply dynamics and manufacturing costs. Wegovy doses start at £79.99 for the 0.25mg starter pen (with discount code FIRST40), progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for the 2.4mg maintenance dose. Our bundle options provide convenient multi-month supplies, such as the Intro Trio (0.25mg, 0.5mg, 1mg) for £299.99.
Mounjaro pricing follows a different structure, reflecting its dual-agonist formulation and manufacturing complexity. Both medications represent significant investment in weight management, but comparing Wegovy vs Mounjaro doses requires considering long-term treatment costs alongside clinical effectiveness. Our clinical assessment process ensures you receive the most appropriate medication, with returning customers using discount code DOSE25 at checkout.
Clinical Evidence: Wegovy vs Mounjaro Doses in Published Trials
The STEP programme provides robust evidence for Wegovy dose effectiveness, with STEP 1 demonstrating ~15% average weight loss at 68 weeks compared to ~2.4% with placebo (Wilding et al., NEJM, 2021). STEP 3 showed ~clinically studied weight loss when combined with intensive behavioural therapy, whilst STEP 5 confirmed ~clinically studied weight loss sustained at two years.
Mounjaro's SURMOUNT trials showed different results using their dose escalation protocol, but direct comparison between Wegovy vs Mounjaro doses isn't straightforward due to different trial designs, patient populations, and endpoints. Both studies demonstrate that patients taking these medications alongside diet and exercise may achieve clinically meaningful weight loss, though individual results vary significantly.
How Wegovy Doses Work: GLP-1 Mechanism Explained
Wegovy's dose escalation protocol maximises GLP-1 receptor activation whilst minimising side effects through gradual introduction. The medication mimics glucagon-like peptide-1, a hormone naturally released when you eat, which signals fullness to your brain and slows gastric emptying. This dual action means smaller meals feel more satisfying, and you may experience reduced food cravings between meals. The weekly injection maintains consistent semaglutide levels, with each dose increase building tolerance and therapeutic effect. Starting at 0.25mg allows your digestive system to adapt, whilst the final 2.4mg maintenance dose provides optimal appetite regulation for long-term weight management.
Ordering Process: Wegovy vs Mounjaro Doses Through EverydayMeds
Our streamlined process makes accessing either Wegovy vs Mounjaro doses straightforward through clinical assessment and prescriber review. The three-minute online assessment gathers medical history, current medications, and weight management goals to determine suitability for either treatment option. Our prescribers review applications within three working days (or 24 hours with express service), ensuring appropriate dose selection and safety screening. Once approved, both medications ship via next-day cold-chain delivery, maintaining the 2-8°C storage requirement until they reach your door. Our GPhC #9012878 registered pharmacy ensures full compliance with MHRA regulations for prescription-only medicines.
Storage and Practical Considerations: Wegovy vs Mounjaro Doses
Storage requirements represent a key practical difference when comparing Wegovy vs Mounjaro doses for UK patients. Wegovy pens maintain potency for up to six weeks at room temperature (below 30°C) once removed from refrigeration, compared to Mounjaro's 21-day limit, making Wegovy more convenient for travel or temporary storage issues. Both medications require refrigeration at 2-8°C before first use, utilising FlexTouch (Wegovy) or KwikPen (Mounjaro) injection systems. The dose escalation schedules differ, with Wegovy's five-step protocol taking 16 weeks to reach maintenance dose, whilst Mounjaro reaches maximum effectiveness more rapidly. Weekly injection timing remains consistent for both treatments, typically administered on the same day each week.
UK Clinical Trial Results: Real-World Wegovy vs Mounjaro Doses Evidence
UK-specific data from post-marketing surveillance and real-world evidence studies provides additional context for Wegovy vs Mounjaro doses effectiveness. The SELECT cardiovascular outcomes trial demonstrated 20% reduction in major cardiovascular events with Wegovy's dosing protocol, particularly relevant for UK patients with obesity-related comorbidities. NHS prescription data suggests good tolerance of Wegovy's dose escalation schedule amongst British patients, with most completing the titration phase successfully.
Comparative effectiveness research between Wegovy vs Mounjaro doses remains limited due to their different approval timelines and patient populations. Both medications require specialist weight management support according to NICE guidance TA875, emphasising that pharmaceutical intervention works best alongside comprehensive lifestyle modification. Real-world UK outcomes demonstrate that patients achieving best results combine either medication with sustained dietary changes and regular physical activity.
Making Your Choice: Wegovy vs Mounjaro Doses Consultation
Selecting between Wegovy vs Mounjaro doses depends on individual factors including medical history, previous treatment responses, and practical considerations like storage requirements or injection preferences. Our clinical team reviews your assessment to recommend the most suitable option, considering contraindications, drug interactions, and your specific weight management goals. Both medications are available through EverydayMeds with the same rigorous prescriber oversight and next-day delivery service. New customers benefit from discount code FIRST40, whilst returning patients use DOSE25 at checkout, making either treatment option accessible through our streamlined process. The decision ultimately rests with you and your prescriber, based on clinical evidence and individual circumstances rather than marketing claims or anecdotal experiences.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
